患有初级线粒体疾病的患者的发作管理:来自InterERNs线粒体工作组的共识声明
Michelangelo Mancuso1, Maria T Papadopoulou2, Yi Shiau Ng3,4
1Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Pisa, Italy.
European journal of neurology
|April 5, 2024
概括
这项研究为线粒体的安全药物使用提供了专家的共识. 这些建议旨在改善控制和减少原发性线粒体疾病中不良药物事件.
科学领域:
- 神经学 神经学
- 代谢障碍 代谢障碍 代谢障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 主要线粒体疾病 (PMD) 是影响能量代谢的常见遗传疾病.
- 是PMD的频繁且往往严重的表现,影响预后.
- 由于潜在的药物毒性,在PMD中有效的发作管理具有挑战性.
研究的目的:
- 为在线粒体中安全使用药物制定共识指南.
- 为PMD患者提供最佳发作管理的建议.
- 为了减少与PMD治疗相关的药物不良反应的风险.
主要方法:
- 在一个由24名国际专家和患者代表组成的小组中,采用了Delphi技术.
- 通过两轮共识建设,制定了建议.
- 重点是安全的药物使用和线粒体的发作管理策略.
主要成果:
- 在针对线粒体的25种审查药物中,14种药物的安全性达到了共识.
- 现有的扣押管理指南得到了批准,并进行了具体的修改.
- 确定了关键药物例外情况,例如在POLG疾病中使用酸和在GABA转氨酶缺乏症中使用维加巴丁.
结论:
- 制定的建议旨在加强PMD患者的控制.
- 这些指南旨在尽量减少线粒体中与药物相关的不良事件.
- 这种共识支持改善PMD相关患者的临床护理.
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
338
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
338
Arteries of the Lower Limbs
188
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
188
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
288
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
288
Seizures: Classification
340
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
340
Antiepileptic Drugs: Sodium Channel Blockers
530
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
530
Antiepileptic Drugs: GABAergic Pathway Potentiators
389
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
389


